The European Society of Endocrinology (ESE) has published an unfastened entree Revised Clinical Practice Guideline for nan Treatment of Chronic Hypoparathyroidism successful Adults successful nan European Journal of Endocrinology, Volume 193, Issue 5, November 2025.
The Revised Guideline has been developed by an master multidisciplinary sheet chaired by Professor Jens Bollerslev, Faculty of Medicine, University of Oslo, Norway. It is intended arsenic applicable guidance for wellness attraction providers progressive successful nan diagnosis, guidance and monitoring of chronic hypoparathyroidism successful adults.
The Revised Guideline has been endorsed by nan European Society of Endocrine Surgeons and nan Endocrine Society of Australia.
These guidelines person been developed arsenic nan guidance of hypoparathyroidism has changed since nan first ESE objective line was published successful 2015, arsenic has nan knowledge connected diligent load of nan disease, and nan knowing of morbidities.
The Revised Guideline is simply a existent collaboration betwixt objective endocrinologists, methodologists, diligent representatives and nan various disciplines progressive successful hypoparathyroidism specified arsenic nephrology and endocrine surgery."
Professor Jens Bollerslev, Faculty of Medicine, University of Oslo, Norway
A cardinal quality successful nan Revised Guideline is nan redefinition of chronic hypoparathyroidism.
Jens Bollerslev added: "In nan original Guideline, nan meaning of chronic hypoparathyroidism was persisting post-surgery for six months aliases longer. After a systematic reappraisal of nan literature, including 14 studies pinch almost 9,000 patients aft cervix surgery, nan sheet saw that nan incidence of betterment of parathyroid usability accrued by almost 7.5% betwixt six months and 12 months. So, successful nan Revised Guideline, we specify chronic hypoparathyroidism 12 months aliases longer post-surgery."
The Guideline besides provides a very clear curen algorithm for moving from accepted curen to cases wherever parathyroid hormone (PTH) replacement therapy mightiness beryllium introduced, and really to do it.
Patients pinch hypoparathyroidism and their support networks are invited to be nan free online ESE Hypoparathyroidism Patient Forum connected Saturday 15 November 2025 from 10:00-13:00 CET, wherever Professor Bollerslev will coming nan Revised Guideline.
ESE's Clinical Committee leads connected line development, pinch input from experts successful different ESE committees arsenic appropriate. All guidelines are taxable to a rigorous reappraisal process earlier being published, pinch input from ESE's Members and applicable parties specified arsenic diligent support groups.
ESE's Clinical Guideline programme is expanding to supply physicians and patients pinch guidance successful cardinal areas. We will besides soon people Joint Guidance for Healthcare Transition from Paediatric to Adult Endocrine Care jointly pinch nan European Society for Paediatric Endocrinology (ESPE) and successful 2026, a Joint Guideline pinch nan Endocrine Society (US) connected arginine vasopressin deficiency (AVP-D).
Source:
Journal reference:
Bollerslev, J., et al. (2025). Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism successful Adults. European Journal of Endocrinology. doi: 10.1093/ejendo/lvaf222. https://academic.oup.com/ejendo/article/193/5/G49/8321487
English (US) ·
Indonesian (ID) ·